Simulect Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Simulect
P
- Pamine FQ (lactobacillus acidophilus / methscopolamine)
- Pediarix (diphtheria toxoid / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- Pediatrace (trace elements with selenium and iodide)
- Peditrace (trace elements)
- Pedte-Pak-4 (trace elements)
- Pedtrace-4 (trace elements)
- Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316))
- Pentacel (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- pertussis, acellular
- Pfizer-BioNTech COVID-10 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308))
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310))
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Vaccine PF (sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Vaccine PF (sars-cov-2 mrna (tozinameran 5y-11y) vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (Do Not Dilute) (sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (sars-cov-2 mrna (tozinameran) vaccine)
- Phillips Colon Health (bifidobacterium infantis / lactobacillus acidophilus)
- phytase/zinc citrate
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- Pneumovax 23 (pneumococcal 23-polyvalent vaccine)
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- Ponvory (ponesimod)
- PreHevbrio (hepatitis b adult vaccine)
- Prevnar (pneumococcal 7-valent vaccine)
- Prevnar 13 (pneumococcal 13-valent vaccine)
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine)
- Primadophilus Bifidus (bifidobacterium infantis / lactobacillus acidophilus)
- Priorix (measles virus vaccine / mumps virus vaccine / rubella virus vaccine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Prodigen (bifidobacterium infantis / lactobacillus acidophilus)
- Prolia (denosumab)
- ProQuad (measles virus vaccine / mumps virus vaccine / rubella virus vaccine / varicella virus vaccine)
- Provella (bifidobacterium infantis / lactobacillus acidophilus)
- Provenge (sipuleucel-T)
- PTE-4 (trace elements)
- PTE-5 (chromic chloride hexahydrate / copper sulfate / manganese sulfate / selenium / zinc sulfate)
- Pyzchiva (ustekinumab)
More about Simulect (basiliximab)
- Simulect consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.